All news from Anaesthesiology

New Antibiotics Holds Promise to Fight against Bacterial Infections

Biologists at The University of Texas at Austin have developed a method for rapidly screening hundreds of thousands of potential drugs for fighting infections , an innovation that holds promise for combating the growing scourge of antibiotic-resistant bacteria . The method involves engineering bacteria to produce and test molecules that are potentially toxic to themselves. The study was published in the journal  Cell

A New Weapon of Immune System to Fight Tuberculosis

A complete cure for tuberculosis has eluded scientists for more than a century but, now, a Montreal team of researchers may have discovered a new weapon to combat this global killer. The team is re-programming  immune cells to kill TB. These groundbreaking findings were published in the journal  Cell .

Enzyme Regulates Inflammation and Metabolism In Fat Tissue

According to a new study, researchers from Brown University have identified an enzyme that appears the regulate the physiology of both fat types in mice, decreasing inflammation in white fat tissue, while promoting the ability of brown fat to burn calories. New study in mice and humans suggests that an enzyme called SNRK suppresses inflammation in obesity-related 'white fat' while increasing metabolism in heat-producing 'brown fat,' making SNRK an intriguing target in the battle against obesity.

Bethesda System Update Changes Clinical Practice: Thyroid Nodules

The study says that researchers have declared that attempts to standardize reporting and cytological criteria for ?ne-needle aspiration of thyroid nodules and was first introduced in 2009, has been updated from The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Although much of the original TBSRTC remains the same, several "enhancements" have been introduced in the 2017 version based on new data and developments in the field. This was published in thyroid.

One HPV type Infection Strongly Increases Risk of Reinfection in Men

A new analysis of genital human papillomavirus (HPV) in men shows that infection with one HPV type strongly increases the risk of reinfection with the same type. In fact, men who are infected with the type responsible for most HPV-related cancers are 20 times more likely to be reinfected within one year. This increased risk suggests that infection confers no natural immunity against HPV, as is often the case with other viruses.